| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pharmacokinetic study on Z-(±)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent
|
Al-Ghananeem, Abeer M.
|
|
2007
|
60 |
6 |
p. 915-919
|
artikel
|
| 2 |
A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors
|
Saif, Muhammad Wasif
|
|
2007
|
60 |
6 |
p. 871-882
|
artikel
|
| 3 |
Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts
|
Low, Jonathan C.
|
|
2007
|
60 |
6 |
p. 821-829
|
artikel
|
| 4 |
Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro
|
Song, Hairong
|
|
2007
|
60 |
6 |
p. 841-849
|
artikel
|
| 5 |
Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure–activity relationship
|
Katayama, Kazuhiro
|
|
2007
|
60 |
6 |
p. 789-797
|
artikel
|
| 6 |
Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
|
Kim, Jong Gwang
|
|
2007
|
60 |
6 |
p. 863-869
|
artikel
|
| 7 |
Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents
|
Patel, Jyoti B.
|
|
2007
|
60 |
6 |
p. 899-905
|
artikel
|
| 8 |
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model
|
Vassileva, Vessela
|
|
2007
|
60 |
6 |
p. 907-914
|
artikel
|
| 9 |
O4-benzylfolic acid inactivates O6-alkylguanine-DNA alkyltransferase in brain tumor cell lines
|
Johnson, Stewart P.
|
|
2007
|
60 |
6 |
p. 883-889
|
artikel
|
| 10 |
Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer
|
Yong, Wei Peng
|
|
2007
|
60 |
6 |
p. 811-819
|
artikel
|
| 11 |
Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors
|
Guo, Feng
|
|
2007
|
60 |
6 |
p. 799-809
|
artikel
|
| 12 |
Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent
|
Aneja, Ritu
|
|
2007
|
60 |
6 |
p. 831-839
|
artikel
|
| 13 |
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma
|
Cummings, J.
|
|
2007
|
60 |
6 |
p. 921-924
|
artikel
|
| 14 |
Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium–porphyrin complex ATX-70
|
Yumita, Nagahiko
|
|
2007
|
60 |
6 |
p. 891-897
|
artikel
|
| 15 |
Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14C-bortezomib
|
Hemeryck, Alex
|
|
2007
|
60 |
6 |
p. 777-787
|
artikel
|
| 16 |
Tumor specific cytotoxicity of glucosylceramide
|
Oku, Hirosuke
|
|
2007
|
60 |
6 |
p. 767-775
|
artikel
|
| 17 |
Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial
|
Danson, S.
|
|
2007
|
60 |
6 |
p. 851-861
|
artikel
|
Tijdschrift beschrijving